Developed via a patented biological synthesis platform, it leverages engineered bacteria to precisely replicate target PDRN sequences, offering a complete alternative to traditional salmon-derived extraction.
This ensures 100% sequence accuracy, consistent molecular weight, structural homogeneity, and zero animal-derived components, while enabling fully traceable, sustainable, and scalable production to meet global regulatory and market requirements.
Extensive in vitro studies demonstrate potent cell-level benefits across repair, regeneration, anti-aging, and anti-inflammatory functions.
- Fibroblast migration is enhanced to 131% of control, indicating strong wound-healing and skin repair potential.
- Increases type I collagen by 1.5× and type III collagen by 1.1×, outperforming conventional salmon PDRN, which translates into noticeable improvements in skin firmness, elasticity, and wrinkle reduction.
- Effectively inhibits pro-inflammatory mediators, IL-6 and TNF-α, confirming its anti- inflammatory efficacy.
- Achieves up to 93% cell migration when combined with hyaluronic acid within 24 hours, highlighting exceptional synergistic potential for combination formulations.
The controlled fragment length, uniform structure, and optimized sequence of RJMPDRN® REC also contribute to superior transdermal performance and reproducibility, overcoming batch-to-batch variability inherent in traditional extraction methods.
RJMPDRN® REC defines a new standard for DNA-based skin care actives, providing brands with a scientifically validated solution for precision repair, anti-aging, and inflammation control. Its production is fully environmentally responsible, eliminating the need for animal- derived materials and reducing pressure on marine ecosystems, offering a truly sustainable solution that meets the growing demand for ethical and eco-conscious skin care ingredients.
